Testo-Med, Testosterone Mix, 400 mg/ml, 10 ml

Testo-Med 400 mg/ml by Bioniche Pharma is a high-concentration multi-ester parenteral androgenic blend integrating Testosterone Propionate, Testosterone Cypionate, and Testosterone Enanthate. Engineered by Bioniche Pharma to deliver a balanced onset with extended systemic delivery, Bioniche Pharma Testo-Med maintains consistent circulating androgen levels, accelerates cellular protein synthesis, and enhances nitrogen retention for tissue regeneration and growth.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

The combination of short-acting (propionate) and long-acting (cypionate and enanthate) esters in Testo-Med by Bioniche Pharma provides a multi-phase pharmacokinetic release profile. Following deep intramuscular injection, the propionate ester offers rapid systemic availability, while the enanthate and cypionate components undergo sustained enzymatic cleavage to ensure prolonged therapeutic hormone levels. The liberated testosterone binds to intracellular androgen receptors, encouraging muscle tissue hypertrophy, boosting red blood cell production, preserving bone mineral density, and promoting positive nitrogen balance.

INDICATIONS & CLINICAL USE

Indicated for testosterone replacement management in male patients diagnosed with primary or secondary hypogonadal disorders stemming from endogenous androgen insufficiency:

• Primary hypogonadism secondary to orchidectomy, testicular torsion, or surgical castration using Bioniche Pharma Testo-Med.
• Eunuchoid states and congenital or acquired testicular failure.
• Hypopituitarism, hypothalamic-pituitary axis failure, or isolated gonadotropin deficiency.

CONTRAINDICATIONS

• Male patients with diagnosed, suspected, or previously treated prostate carcinoma or breast cancer.
• Female patients, pregnant women, and nursing mothers due to high risks of fetal virilization, developmental defects, and severe endocrine disruption.
• Known hypersensitivity or allergic response to any of the testosterone esters, carrier oils, or compounding excipients in Bioniche Pharma Testo-Med.

WARNINGS & SPECIAL PRECAUTIONS

• Cardiovascular Supervision: Middle-aged and elderly male patients with underlying angina pectoris, ischemic heart disease, or circulatory dysfunction should undergo treatment with Testo-Med by Bioniche Pharma only under close medical monitoring.
• Fluid & Electrolyte Retention: Exogenous androgens promote renal conservation of sodium, potassium, water, and chloride. Careful surveillance is required in patients with a history of congestive heart failure, hypertension, renal dysfunction, epilepsy, or migraine headaches.
• Pediatric & Prepubertal Caution: Contraindicated in pediatric populations and prepubertal males to prevent precocious sexual development and premature epiphyseal closure, which can permanently impair adult height.
• Laboratory Interference: Transient reductions in protein-bound iodine (PBI) levels may occur during Bioniche Pharma Testo-Med therapy without clinical thyroid impairment.

ADVERSE REACTIONS & CLINICAL REASSESSMENT

• Excessive Sexual Stimulation: Priapism, abnormally frequent or persistent penile erections, and heightened sexual desire.
• Reproductive & Endocrine: Oligospermia, reduced ejaculatory volume, testicular suppression, and potential gynecomastia associated with Bioniche Pharma Testo-Med therapy.
• Prepubertal Manifestations: Acceleration of skeletal maturation, phallic enlargement, and precocious puberty.
• Action Plan: If severe androgen-related adverse events develop, treatment with Bioniche Pharma Testo-Med should be suspended temporarily. Upon symptom resolution, therapy may be cautiously re-initiated at a lower, titrated dosage under medical supervision.

DOSAGE & ADMINISTRATION

Testo-Med by Bioniche Pharma is intended strictly for deep intramuscular injection. Dosing regimens must be monitored continuously and adjusted based on clinical response, serum hormone values, and patient tolerance:

• Therapeutic Schedule: Standard clinical administration typically ranges from 400 mg to 2000 mg per week of Bioniche Pharma Testo-Med, customized to individual replacement protocols under qualified medical direction.
• Restricted Populations: Strictly contraindicated for pediatric use, adolescents, and female patients.

STORAGE & HANDLING

Store Bioniche Pharma Testo-Med in a dry, cool location protected from direct sunlight exposure and elevated ambient heat. Do not refrigerate or freeze. Store securely out of the reach and sight of children.